2008
DOI: 10.1186/1475-2859-7-25
|View full text |Cite
|
Sign up to set email alerts
|

Yeast cell factories for fine chemical and API production

Abstract: This review gives an overview of different yeast strains and enzyme classes involved in yeast wholecell biotransformations. A focus was put on the synthesis of compounds for fine chemical and API (= active pharmaceutical ingredient) production employing single or only few-step enzymatic reactions. Accounting for recent success stories in metabolic engineering, the construction and use of synthetic pathways was also highlighted. Examples from academia and industry and advances in the field of designed yeast str… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
67
0
1

Year Published

2009
2009
2018
2018

Publication Types

Select...
6
3
1

Relationship

0
10

Authors

Journals

citations
Cited by 104 publications
(69 citation statements)
references
References 249 publications
1
67
0
1
Order By: Relevance
“…However, a range of commercial manufacturing processes relies on the formation of microbial biofilms (23,25,26). Hence, it may be possible to adapt antibody-mediated immobilization to promote biofilm formation to exploit the industrial use of these microbes.…”
Section: Vol 75 2009 Fungal Cell Immobilization Promotes Biofilm Fomentioning
confidence: 99%
“…However, a range of commercial manufacturing processes relies on the formation of microbial biofilms (23,25,26). Hence, it may be possible to adapt antibody-mediated immobilization to promote biofilm formation to exploit the industrial use of these microbes.…”
Section: Vol 75 2009 Fungal Cell Immobilization Promotes Biofilm Fomentioning
confidence: 99%
“…Whole-cell biotransformations with recombinant microbes offer many advantages with respect to scalable metabolite production, and corresponding expression systems for human P450s have thus been established in bacteria and yeasts (Ghisalba and Kittelmann, 2007;Pscheidt and Glieder, 2008). In recent years, we showed the usefulness of recombinant strains of the fission yeast Schizosaccharomyces pombe that express human P450s for the production of P450 metabolites of illicit drugs (Peters et al, 2009) and doping substances (Zöllner et al, in press).…”
mentioning
confidence: 99%
“…La genómica funcional también ha dado lugar a una nueva visión de la ingeniería genética dándole un potencial más amplio convirtiéndose, más bien, en una "ingeniería genómica" (Carr & Church 2009), pasando de la ingeniería metabólica (Graham et al 2007, Lee et al 2009, Stephanopoulos 2002, Ye & Bathia 2012 y la evolución dirigida (Chatterjee & Yuan 2006, Lin et al 2009, Turner 2003) a la construcción de "factorías celulares" (Barnes & Dickson 2006, Mapari et al 2009, Pscheidt & Glieder 2008, Villaverde 2010) y recientemente a la biología sintética (Aldrich et al 2008, Endy 2008, Gibson et al 2010, Sismour & Benner 2005. Otro desarrollo que vale la pena resaltar es el advenimiento de la metagenómica que está permitiendo por un lado, estudiar y entender más profundamente la ecología de microorganismos y, de otro, la identificación de nuevas especies microbianas hasta ahora elusivas a su estudio (Langer et al 2006, Riesenfeld et al 2004, Schmeisser et al 2007, Warnecke & Hugenholtz 2007.…”
Section: Algunos Logros En Biotecnologíaunclassified